MMPAD Munich Meeting Report

MEETING REPORT 10 European Roadshow - Friday 25 th May, 2018 Munich, Germany People with diabetes, who have had more than one hypoglycaemic episode while awake, and which required help from others within the last 12 months, should not drive until metabolic stability and awareness of low blood sugar levels is ensured. Prevention of hypoglycaemia According to Holl, every severe hypoglycaemic episode is a chance to prevent the next one. Thus for prevention, he suggested not only to adapt insulin therapy and continuously monitor blood glucose levels, but also to regularly check injection sites, because little bumps lead to varying absorption of insulin. The speaker was convinced that the focus on blood sugar concentration will change in the near future due to technological innovation. To date, however, not every patient has access to continuous blood glucose monitoring devices. Fast relief Hypoglycaemic patients who are conscious should be treated urgently with quickly absorbable carbohydrates (1–2 units of glucose, juice or dextrose and 1 unit of long-lasting carbohydrates). The future also looks promising for intranasal glucagon, because many parents are uncomfortable with injecting glucagon intramuscularly, Holl said. The intranasal application may lower the treatment threshold as children with a bodyweight of less than 20 kilograms should only receive half the dose of intranasal glucagon. Figure 2 : Severe hypoglycaemia (SH) rate compared with the range of HbA1c values (slide: Holl ). 11 HbA 1C % category An extract from Professor Holl's presentation is available here